Title:
医薬化合物
Document Type and Number:
Japanese Patent JP7326305
Kind Code:
B2
Abstract:
The invention provides new pyrazine derivatives of formula (I):or a tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined herein. The invention also provides pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Inventors:
Christopher, Norbert, Johnson
Ildico, maria, back
Gianni, Cessari
James, Edward, Harvey, Day
Sakae Fujiwara
Christopher, Charles, Frederick, Hamlet
Stephen, Douglas, Hiscock
Ryan, Sarah, Holby
Steven, Howard
John, Walter, Ribeschutz
Nicholas, John, Palmer
Jeffrey, David, Estee, Dennis
David, Jeffrey, Twig
Andrew, James, Woodhead
Ildico, maria, back
Gianni, Cessari
James, Edward, Harvey, Day
Sakae Fujiwara
Christopher, Charles, Frederick, Hamlet
Stephen, Douglas, Hiscock
Ryan, Sarah, Holby
Steven, Howard
John, Walter, Ribeschutz
Nicholas, John, Palmer
Jeffrey, David, Estee, Dennis
David, Jeffrey, Twig
Andrew, James, Woodhead
Application Number:
JP2020544607A
Publication Date:
August 15, 2023
Filing Date:
March 01, 2019
Export Citation:
Assignee:
Otsuka Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd.
International Classes:
C07D487/04; A61K31/4985; A61K31/4995; A61K45/00; A61P35/00; A61P43/00; C07D519/00
Foreign References:
| WO2017210134A1 | ||||
| WO2016203404A1 |
Attorney, Agent or Firm:
Yukitaka Nakamura
Satoru Asakura
Mari Asano
Hiroshi Sorimachi
Keiyasu Suzuki
Satoru Asakura
Mari Asano
Hiroshi Sorimachi
Keiyasu Suzuki